BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19575850)

  • 21. Clinical features and the molecular biomarkers of olfactory neuroblastoma.
    Peng X; Liu Y; Peng X; Wang Z; Zhang Z; Qiu Y; Jin M; Wang R; Kong D
    Pathol Res Pract; 2018 Aug; 214(8):1123-1129. PubMed ID: 29921494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Olfactory neuroblastoma associated with extensive "in situ" lesion and aberrant glandular and rhabdomyosarcomatous differentiation.
    Shintaku M; Ohta M; Kataoka K; Okabe H
    Neuropathology; 2021 Aug; 41(4):273-280. PubMed ID: 33951746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcription Factor Expression in Sinonasal Neuroendocrine Neoplasms and Olfactory Neuroblastoma (ONB): Hyams' Grades 1-3 ONBs Expand the Spectrum of SATB2 and GATA3-Positive Neoplasms.
    Uccella S; Facco C; Chiaravalli AM; Pettenon F; La Rosa S; Turri-Zanoni M; Castelnuovo P; Cerati M; Sessa F
    Endocr Pathol; 2022 Jun; 33(2):264-273. PubMed ID: 35522392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment modalities and outcomes of olfactory neuroblastoma.
    Song CM; Won TB; Lee CH; Kim DY; Rhee CS
    Laryngoscope; 2012 Nov; 122(11):2389-95. PubMed ID: 23070733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Olfactory neuroblastoma with focal ganglioneuroblastic differentiation: a case report with literature review.
    Squillaci S
    Pathologica; 2014 Jun; 106(2):61-6. PubMed ID: 25291869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SSTR2 Expression in Olfactory Neuroblastoma: Clinical and Therapeutic Implications.
    Cracolici V; Wang EW; Gardner PA; Snyderman C; Gargano SM; Chiosea S; Singhi AD; Seethala RR
    Head Neck Pathol; 2021 Dec; 15(4):1185-1191. PubMed ID: 33929681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metastasizing Esthesioneuroblastoma in a Dog.
    Siudak K; Klingler M; Schmidt MJ; Herden C
    Vet Pathol; 2015 Jul; 52(4):692-5. PubMed ID: 25428407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Evidence for Olfactory Neuroblastoma as a Tumor of Malignant Globose Basal Cells.
    Zunitch MJ; Fisch AS; Lin B; Barrios-Camacho CM; Faquin WC; Tachie-Baffour Y; Louie JD; Jang W; Curry WT; Gray ST; Lin DT; Schwob JE; Holbrook EH
    Mod Pathol; 2023 May; 36(5):100122. PubMed ID: 36841178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microvessel density and Ki-67 labeling index in esthesioneuroblastoma: is there a prognostic role?
    Singh L; Ranjan R; Madan R; Arava SK; Deepak RK; Singh MK
    Ann Diagn Pathol; 2015 Dec; 19(6):391-6. PubMed ID: 26343569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathologic Features and Prognosis of Olfactory Neuroblastoma with Isocitrate Dehydrogenase 2 Mutations.
    Wu L; An J; Liu H
    World Neurosurg; 2022 Mar; 159():e23-e31. PubMed ID: 34856401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical analysis of 53 cases of esthesioneuroblastoma].
    Chen YF; Yang AK; Zhang Q; Ouyang D; Chen WK; Chen FJ
    Ai Zheng; 2009 Mar; 28(3):308-11. PubMed ID: 19619448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Olfactory neuroblastoma: a review and update.
    Faragalla H; Weinreb I
    Adv Anat Pathol; 2009 Sep; 16(5):322-31. PubMed ID: 19700942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression of SSTR2 and P-STAT3 in human olfactory neuroblastoma].
    Zeng M; Cui Y; Wu C
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Aug; 24(15):690-2. PubMed ID: 20942237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatment.
    Czapiewski P; Kunc M; Haybaeck J
    Oncotarget; 2016 Aug; 7(32):52584-52596. PubMed ID: 27256979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Olfactory Neuroblastoma: A Case Report.
    Olmo HR; Stokes SM; Foss RD
    Head Neck Pathol; 2016 Jun; 10(2):256-60. PubMed ID: 26316323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Olfactory neuroblastoma: the University of Erlangen-Nuremberg experience 1975-2000.
    Constantinidis J; Steinhart H; Koch M; Buchfelder M; Schaenzer A; Weidenbecher M; Iro H
    Otolaryngol Head Neck Surg; 2004 May; 130(5):567-74. PubMed ID: 15138422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mixed Olfactory Neuroblastoma and Adenocarcinoma with In Situ Neuroendocrine Hyperplasia.
    Attwood JE; Jeyaretna DS; Sheerin F; Shah KA
    Head Neck Pathol; 2020 Sep; 14(3):792-798. PubMed ID: 31388897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of the human Achaete-scute 1 gene in olfactory neuroblastoma (esthesioneuroblastoma).
    Carney ME; O'Reilly RC; Sholevar B; Buiakova OI; Lowry LD; Keane WM; Margolis FL; Rothstein JL
    J Neurooncol; 1995 Oct; 26(1):35-43. PubMed ID: 8583243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Olfactory neuroblastoma. Presentation of a case].
    Rais M; Ferreli F; Avataneo MC; Nicolosi A; Massidda B
    Pathologica; 1995 Oct; 87(5):548-50. PubMed ID: 8868186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of bcl-2 is associated with microvessel density in olfactory neuroblastoma.
    Diensthuber M; Potinius M; Rodt T; Stan AC; Welkoborsky HJ; Samii M; Schreyögg J; Lenarz T; Stöver T
    J Neurooncol; 2008 Sep; 89(2):131-9. PubMed ID: 18431543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.